About Delee
Delee is a company based in Laredo (United States) founded in 2017.. Delee has raised $1.3 million across 2 funding rounds from investors including Y Combinator. The company has 3 employees as of December 31, 2022. Delee offers products and services including CytoCatch Isolation Platform and CytoCatch Imaging System. Delee operates in a competitive market with competitors including Scholar Rock, Lightpoint Medical, Chromition, Nodexus and Preora Healthcare, among others.
- Headquarter Laredo, United States
- Employees 3 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Delee Corp
-
Annual Revenue
$55.61 K0as on Mar 21, 2021
-
Net Profit
$-37.21 K92as on Dec 31, 2022
-
EBITDA
-
Total Equity Funding
$1.3 M (USD)
in 2 rounds
-
Latest Funding Round
$1.18 M (USD), Seed
Dec 09, 2019
- Investors
-
Employee Count
3
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Delee
Delee offers a comprehensive portfolio of products and services, including CytoCatch Isolation Platform and CytoCatch Imaging System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated system for high-efficiency isolation of circulating tumor cells.
AI-driven tool for classifying and enumerating tumor cells in samples.
Unlock access to complete
Unlock access to complete
Funding Insights of Delee
Delee has successfully raised a total of $1.3M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.18 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.2M
-
First Round
First Round
(01 Jun 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Seed - Delee | Valuation |
investors |
|
| Jun, 2017 | Amount | Seed - Delee | Valuation | Y Combinator |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Delee
Delee has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Delee
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Delee
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Delee Comparisons
Competitors of Delee
Delee operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scholar Rock, Lightpoint Medical, Chromition, Nodexus and Preora Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-based drugs for primary myopathies are developed and targeted.
|
|
| domain | founded_year | HQ Location |
Intraoperative imaging devices for real-time cancer detection are developed.
|
|
| domain | founded_year | HQ Location |
Nanoparticle-based solutions for displays and lighting are provided.
|
|
| domain | founded_year | HQ Location |
Microfluidic systems are developed for detecting metastatic cancer.
|
|
| domain | founded_year | HQ Location |
Pre-screening cancer tests are offered via nanoscale cytology platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Delee
When was Delee founded?
Delee was founded in 2017.
Where is Delee located?
Delee is headquartered in Laredo, United States. It is registered at Laredo, Texas, United States.
Is Delee a funded company?
Delee is a funded company, having raised a total of $1.3M across 2 funding rounds to date. The company's 1st funding round was a Seed of $125K, raised on Jun 01, 2017.
How many employees does Delee have?
As of Dec 31, 2022, the latest employee count at Delee is 3.
What is the annual revenue of Delee?
Annual revenue of Delee is $55.61K as on Mar 21, 2021.
What does Delee do?
Delee was founded in 2017 in Laredo, United States, and operates in the medical device sector focused on oncology. The CytoCatch device, comprising an isolation platform and imaging system, is utilized to separate and examine circulating tumor cells from blood samples. This technology supports ongoing assessment of cancer progression and therapy outcomes in clinical settings.
Who are the top competitors of Delee?
Delee's top competitors include Scholar Rock, Lightpoint Medical and Nodexus.
What products or services does Delee offer?
Delee offers CytoCatch Isolation Platform and CytoCatch Imaging System.
Who are Delee's investors?
Delee has 1 investor. Key investors include Y Combinator.